このアイテムのアクセス数: 121

このアイテムのファイル:
ファイル 記述 サイズフォーマット 
j.stemcr.2024.09.008.pdf291.37 kBAdobe PDF見る/開く
完全メタデータレコード
DCフィールド言語
dc.contributor.authorFujita, Misaoen
dc.contributor.authorHatta, Taichien
dc.contributor.authorIkka, Tsunakunien
dc.contributor.authorOnishi, Tatsuoen
dc.contributor.alternative藤田, みさおja
dc.contributor.alternative八田, 太一ja
dc.contributor.alternative一家, 綱邦ja
dc.contributor.alternative大西, 達夫ja
dc.date.accessioned2024-11-18T02:43:00Z-
dc.date.available2024-11-18T02:43:00Z-
dc.date.issued2024-11-12-
dc.identifier.urihttp://hdl.handle.net/2433/290369-
dc.descriptionエクソソーム治療に関する規制整備の必要性を指摘した論文が発表されました. 京都大学プレスリリース. 2024-10-25.ja
dc.description.abstractTurner and colleagues recently argued that countries with unclear laws and regulations regarding stem cells, exosomes, and other regenerative medicine products should develop and enforce more comprehensive regulatory structures. We fully agree with this opinion and discuss that failure to do so may lead to troubling predicaments, such as the Japanese cases, where patients are at risk of serious complications or even death.en
dc.language.isoeng-
dc.publisherElsevier BVen
dc.rights© 2024 The Author(s). Published by Elsevier Inc. on behalf of International Society for Stem Cell Research.en
dc.rightsThis is an open access article under the CC BY-NC-ND license.en
dc.rights.urihttps://creativecommons.org/licenses/by-nc-nd/4.0/-
dc.titleThe urgent need for clear and concise regulations on exosome-based interventionsen
dc.typejournal article-
dc.type.niitypeJournal Article-
dc.identifier.jtitleStem cell reportsen
dc.identifier.volume19-
dc.identifier.issue11-
dc.identifier.spage1517-
dc.identifier.epage1519-
dc.relation.doi10.1016/j.stemcr.2024.09.008-
dc.textversionpublisher-
dc.addressUehiro Research Division for iPS Cell Ethics, Center for iPS Cell Research and Application (CiRA), Kyoto University; Institute for the Advanced Study of Human Biology (WPI-ASHBi), KUIAS, Kyoto Universityen
dc.addressGraduate School of Public Health, Shizuoka Graduate University of Public Healthen
dc.addressDivision of Bioethics & Healthcare Law, Institute for Cancer Control, National Cancer Center Japan; Division of Bioethics, Center for Research Administration and Support, National Cancer Center Japanen
dc.addressMLIP Law Officeen
dc.identifier.pmid39454583-
dc.relation.urlhttps://www.cira.kyoto-u.ac.jp/j/pressrelease/news/241025-100000.html-
dcterms.accessRightsopen access-
dc.identifier.eissn2213-6711-
出現コレクション:学術雑誌掲載論文等

アイテムの簡略レコードを表示する

Export to RefWorks


出力フォーマット 


このアイテムは次のライセンスが設定されています: クリエイティブ・コモンズ・ライセンス Creative Commons